Orange Book product · Generic (ANDA)
CALCIPOTRIENE
CALCIPOTRIENE
At a glance
May 06, 2008
Approved
Generic (ANDA)
Application
AT
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 06, 2008
18 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CALCIPOTRIENE
Strength
0.005%
Dosage form
SOLUTION
Route
TOPICAL
TE code
AT
Application
ANDA 078305
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CALCIPOTRIENE
- 2010SORILUXBrand (NDA)
NDA 022563 · MAYNE PHARMA
- 1997DOVONEXBrand (NDA)
NDA 020611 · LEO PHARM
- 1996DOVONEXBrand (NDA)
NDA 020554 · LEO PHARMA AS
- 1993DOVONEXBrand (NDA)
NDA 020273 · LEO PHARMA AS
- 2017CALCIPOTRIENEGeneric (ANDA)
ANDA 207163 · CHARTWELL RX
- 2015CALCIPOTRIENEGeneric (ANDA)
ANDA 205772 · GLENMARK SPECLT
- 2012CALCIPOTRIENEGeneric (ANDA)
ANDA 200935 · CHARTWELL RX
- 2011CALCIPOTRIENEGeneric (ANDA)
ANDA 078468 · COSETTE PHARMS NC
- 2010CALCIPOTRIENEGeneric (ANDA)
ANDA 090633 · GLENMARK PHARMS
- 2009CALCIPOTRIENEGeneric (ANDA)
ANDA 077029 · CHARTWELL RX
- 2009CALCIPOTRIENEGeneric (ANDA)
ANDA 077579 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
